Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» reproxalap
reproxalap
Aldeyra shows FDA-rejected reproxalap improves eye discomfort in new phase 3 study
Fierce Biotech
Thu, 08/8/24 - 10:25 pm
Aldeyra Therapeutics
dry eye disease
reproxalap
FDA
FDA Rejects Aldeyra’s Dry Eye Drug, Cites Need for Additional Trial
BioSpace
Wed, 11/29/23 - 12:03 pm
Aldeyra Therapeutics
reproxalap
FDA
dry eye disease
Aldeyra Anticipates FDA Rejection of Dry Eye Drug Following Regulatory Meeting
BioSpace
Tue, 10/17/23 - 10:17 am
Aldeyra Therapeutics
dry eye disease
reproxalap
FDA
Aldeyra reports positive data from dry eye disease therapy trial
Clinical Trials Arena
Wed, 03/1/23 - 10:08 am
Aldeyra Therapeutics
clinical trials
reproxalap
dry eye disease
Aldeyra’s sights set on November PDUFA
Endpoints
Tue, 02/7/23 - 11:57 am
Aldeyra Therapeutics
dry eye disease
reproxalap
FDA
Aldeyra says eye drop clears three dry eye signals en route to FDA
Endpoints
Tue, 07/12/22 - 10:51 am
Aldeyra Therapeutics
dry eye disease
FDA
clinical trials
reproxalap
Aldeyra Prepares to Submit Dry Eye Disease Treatment Reproxalap to FDA
BioSpace
Thu, 06/9/22 - 10:22 am
Aldeyra Therapeutics
dry eye disease
reproxalap
clinical trials
Aldeyra builds case for troubled dry eye drug reproxalap
Pharmaforum
Wed, 01/12/22 - 10:52 am
Aldeyra Therapeutics
dry eye disease
reproxalap
Watch out Claritin: Aldeyra announces clean sweep in PhIII for new allergy drug
Endpoints
Tue, 04/27/21 - 11:21 pm
Aldeyra Therapeutics
clinical trials
allergies
reproxalap
ragweed pollen allergy
3 Biotech Stocks That Jumped Last Week
Motley Fool
Sun, 01/17/21 - 04:54 pm
biotech
biotech stocks
Lexicon Pharmaceuticals
sotagliflozin
Nucana
Aldeyra Therapeutics
reproxalap
Aldeyra's Reproxalap Falls Short in Anterior Uveitis Trial
BioSpace
Wed, 06/26/19 - 10:39 am
Aldeyra Therapeutics
reproxalap
non-infectious anterior uveitis
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
Xconomy
Tue, 03/26/19 - 09:45 am
Aldeyra Therapeutics
clinical trials
FDA
eye health
reproxalap
seasonal allergic conjunctivitis
Aldeyra plans reproxalap phase 3 after wrapping up dry eye disease trial
Fierce Biotech
Wed, 09/26/18 - 10:02 am
Aldeyra Therapeutics
dry eye disease
clinical trials
reproxalap